Genetic material from clade I mpox turned up in sewage near one of the most recognizable military installations in the Pacific, marking the first time the more severe strain of the virus has been found in any Hawaii wastewater sample.
The Hawaii Department of Health announced that a specimen collected on April 13, 2026, at the Joint Base Pearl Harbor-Hickam wastewater treatment facility on Oahu tested positive for clade I mpox. No one in the state has been clinically diagnosed with the strain. In its news release, the department stated that “the risk to the general public remains low” and that “no cases of clade I mpox have been identified in Hawaii.”
Still, the detection lands at a moment when clade I mpox is no longer confined to Central and Eastern Africa, where it originated. The strain has been identified on the U.S. mainland, including in Los Angeles County, where officials last October confirmed a third clade I case in a person with no recent international travel, raising the prospect of domestic person-to-person spread. No publicly available update from LA County or the CDC has indicated whether further cases linked to that cluster were confirmed in the months since.
What wastewater testing can and cannot tell us
Hawaii’s wastewater surveillance program is run in partnership with the state laboratory, CDC National Wastewater Surveillance System contract partners, and WastewaterSCAN, according to the Department of Health’s Disease Outbreak Control Division. The system is designed as an early warning tool, not a clinical diagnostic.
A positive signal means viral genetic material was present in sewage. That material could come from someone actively infected, a person still shedding virus after recovery, or a traveler passing through the area the treatment plant serves. It does not, on its own, confirm that anyone nearby is currently sick.
The CDC has cautioned that mpox detections in wastewater can fall near or below assay detection limits, producing faint signals that may be difficult to reproduce. A peer-reviewed analysis in the agency’s Morbidity and Mortality Weekly Report, covering U.S. data from August 2022 through May 2023, found that wastewater monitoring had the sensitivity to pick up a single mpox case within a large catchment area. That same study concluded that an isolated detection typically warrants a limited response, such as heightened clinical awareness and targeted testing, rather than broad emergency measures. Hawaii’s characterization of low public risk tracks with that federal guidance.
One important caveat: the MMWR analysis was based on clade II data. Clade I may differ in shedding patterns, and researchers have not yet published equivalent wastewater-sensitivity findings specific to the newer strain.
Why clade I matters more
The distinction between clades is not academic. Clade I mpox has historically carried a higher case-fatality rate in endemic settings than clade II, the strain responsible for the global outbreak that began in 2022. The CDC’s outbreak tracking page, which documents the clade I outbreak that emerged internationally beginning in 2023, notes that the agency expects additional clade I cases in the United States as international travel continues.
The Jynneos vaccine, already authorized in the United States for mpox prevention, is expected to offer cross-clade protection, though real-world effectiveness data against clade I in non-endemic populations is still limited.
Unanswered questions around Pearl Harbor
The Department of Health’s announcement left several gaps. It did not disclose the viral concentration in the April 13 sample, so outside scientists cannot judge whether the signal was strong or borderline. Without that detail, it is impossible to estimate whether the result reflects one shedding individual, multiple infections, or a reading that might not replicate in follow-up testing.
No public statement has come from Joint Base Pearl Harbor-Hickam or the Department of Defense. The Honolulu Star-Advertiser and other local outlets have not published any on-the-record response from base officials as of late April 2026. The base serves a mixed population of active-duty service members, military families, civilian employees, and contractors, many of whom rotate through international postings in regions where clade I mpox has been reported. Whether the military has launched its own contact tracing, clinical screening, or expanded wastewater sampling remains unclear. The state’s release did not describe any coordination with Defense Department health authorities, and requests for comment from base public affairs have not yielded a public response.
Hawaii’s mpox case dashboard, maintained by the Disease Outbreak Control Division, tracks confirmed infections by year and county, but the most recent publicly available counts cover 2025 and reflect clade II cases. No updated data tied to post-April 2026 surveillance has been published, leaving a gap between the wastewater finding and whatever clinical follow-up may be underway.
What residents and military families should know
Mpox spreads primarily through prolonged skin-to-skin contact with an infected person, contact with contaminated materials such as bedding, and, less commonly, through respiratory droplets during extended face-to-face interaction. Symptoms typically include fever, body aches, swollen lymph nodes, and a distinctive rash that progresses through several stages before scabbing over.
The Department of Health’s news release urged health-care providers across the state to “maintain a high index of suspicion” for symptoms consistent with mpox and to test promptly when clinical suspicion arises. Residents who develop an unexplained rash, particularly after close contact with someone who has traveled internationally, should contact a health-care provider.
Jynneos vaccination is available in Hawaii for people at elevated risk. Those who believe they may have been exposed or who fall into higher-risk categories can reach out to their primary care provider or the state health department for guidance on eligibility.
Tracking the wastewater signal from here
The most telling data will come from trend monitoring, not this single sample. Repeated detections at the same facility, rising viral concentrations, or new signals at other Oahu treatment plants would all point toward a more serious situation and could trigger a stronger public health response. If follow-up samples come back negative and no clinical cases surface, the April 13 result may amount to an isolated blip.
For now, Hawaii’s first clade I mpox wastewater signal is best understood as an early alert in a global story that is still developing. It confirms that the state is not insulated from a virus that has already crossed oceans and continents, but it does not, by the evidence available in late April 2026, signal an outbreak on Oahu.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
